BioPoint, Inc. Named to Boston Business Journal’s 2017 Fast 50 Awards List

WAKEFIELD, Mass., May 17, 2017 /PRNewswire/ — For the second straight year, life sciences workforce solutions and consulting services firm BioPoint (http://biopointinc.com/) has earned a spot on the Boston Business Journal Fast 50 — a highly regarded annual list of the 50 fastest-growing private companies in Massachusetts.Boston Business Journal Fast 50

“The Fast 50 award is a testament to the professionalism, dedication, and commitment to excellence of our entire team,” says BioPoint co-founder Chris Nash. “Being recognized as a top private company in the state is a great honor; two years in a row is incredible. Looking ahead, we’re going to strive to build on the expertise and results which have allowed us to earn our clients’ trust, and to forge new client partnerships.”

Founded in 2011, BioPoint has experienced strong revenue growth virtually from day one. The firm has met the demands of a burgeoning industry with a client-focused approach that’s culminated in both awards and a positive reputation. Last year, BioPoint was named to the Inc. 5000 list of fastest-growing U.S. companies for the second year in a row; in 2015, the firm was singled out as the fastest-growing private enterprise in Massachusetts.

Fellow co-founder George Kokoros echoed Nash’s sentiments regarding this most recent accolade: “BioPoint is honored to be on the Boston Business Journal Fast 50 for the second straight year. The competition this time around was intense, as Massachusetts has become home to many of the world’s top biotech and life sciences institutions and companies.”

More than 150 companies were nominated for the 2017 edition of the Fast 50. To be considered, nominees had to have generated revenue of at least $500,000 in 2013 and $1 million in 2016. The Boston Business Journal’s research department, together with CPA firm Withun, analyzed the relevant financial numbers to determine which companies made the final cut. Revenue growth trends over the prior 3 years is an important variable in the Fast 50 formula; for its part, BioPoint has seen exceptional gains during that span.

BioPoint is a provider of management consulting services designed to help Life Sciences clients bring products/devices to market more effectively and successfully, in an increasingly regulated and value driven healthcare marketplace. Most recently, the firm began its Full Service Provider (FSP) model, which enable clients to secure specialized consulting services on a more flexible as-needed basis. As such, the firm’s experts are available at a moment’s notice to provide on-site or remote consultations throughout all phases of product development. BioPoint’s knowledge and practice areas include Drug Safety/Pharmacovigilance, Regulatory Affairs, Market Access/HEOR and Quality Assurance.

The remainder of 2017 will see continued dynamic growth for BioPoint. The firm has plans to significantly add to its workforce as it opens regional offices in Chicago and San Francisco. Additionally, the BioPoint team eagerly awaits the announcement of this year’s Inc. 5000 list, as they anticipate earning a spot for the third straight year.

About BioPoint, Inc.

BioPoint, Inc. is a leading global workforce solutions and consulting services firm that combines deep life sciences industry knowledge with specialized expertise in drug safety, health economics and outcomes research, regulatory affairs, quality assurance, compliance and risk mitigation. Our professionals have assisted clients in optimizing their businesses, improving their operations and risk profile, and advancing their organizational performance to seize key opportunities.